Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

GPCRStructure Therapeutics Inc.

Nasdaq · CIK 0001888886
Filer categoryLarge accelerated filer
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts230

Identity from submissions API

NameStructure Therapeutics Inc.
CIK0001888886
TickersGPCR
ExchangesNasdaq
Entity typeoperating
CategoryLarge accelerated filer
SIC2834 Pharmaceutical Preparations
EIN981480821
LEI—
Fiscal year end1231
State of incorporationE9 Cayman Islands
Phone(650) 457-1978
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • ShouTi Inc. (2021-10-21T04:00:00.000Z → 2022-05-13T04:00:00.000Z)
Business address
601 GATEWAY BLVD SUITE 900
SOUTH SAN FRANCISCO
CA
94080
CA
Mailing address
601 GATEWAY BLVD SUITE 900
SOUTH SAN FRANCISCO
CA
94080
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

275 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000902219-26-000324 005-93902 261557749 34 17449
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-005075 005-93902 261555790 34 11853
2026-11-09 10-Q 10-Q 0001104659-26-124503 001-41608 261536169 34 8316718 1 1
2026-11-09 8-K FORM 8-K 2.02,9.01 0001104659-26-124494 001-41608 261536066 34 333238 1 1
2026-11-05 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-002858 005-93902 261526316 34 11799
2026-09-22 4 xslF345X06/form4-09222026_090944.xml 0002037144-26-000004 11884
2026-09-21 144 xsl144X01/primary_doc.xml 0001950047-26-009722 001-41608 261394371 33 4985
2026-09-08 8-K FORM 8-K 7.01,8.01,9.01 0001104659-26-105688 001-41608 261363456 34 7957335 1 1
2026-09-02 4 xslF345X06/form4-09032026_010924.xml 0001962926-26-000009 19518
2026-08-19 4 xslF345X06/form4-08202026_120854.xml 0001962926-26-000008 19913
2026-08-07 4 xslF345X06/form4-08072026_080836.xml 0002148420-26-000006 8170
2026-08-07 3 xslF345X06/form3-08072026_080856.xml 0002148420-26-000005 8169
2026-08-06 10-Q 10-Q 0001104659-26-092057 001-41608 261249607 34 7343271 1 1
2026-08-06 8-K FORM 8-K 2.02,9.01 0001104659-26-092017 001-41608 261249228 34 357443 1 1
2026-08-06 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-002142 005-93902 261247252 34 11792
2026-08-05 4 xslF345X06/form4-08052026_080829.xml 0001962926-26-000007 17322
2026-07-24 4 4 0001193125-26-315240 13013
2026-07-15 4 xslF345X06/form4-07152026_100751.xml 0001962926-26-000006 17325
2026-06-29 4 xslF345X06/form4-06302026_120631.xml 0001962926-26-000005 14332
2026-06-25 144 xsl144X01/primary_doc.xml 0001950047-26-006512 001-41608 261122266 33 5111
2026-06-18 4 xslF345X06/form4-06182026_050614.xml 0001534002-26-000002 6213
2026-06-18 4 xslF345X06/form4-06182026_050611.xml 0001188919-26-000010 6236
2026-06-18 4 xslF345X06/form4-06182026_050609.xml 0001962413-26-000002 6248
2026-06-18 4 xslF345X06/form4-06182026_050606.xml 0001202785-26-000004 6207
2026-06-18 4 xslF345X06/form4-06182026_050604.xml 0001328565-26-000002 6235
2026-06-18 4 xslF345X06/form4-06182026_050603.xml 0001206199-26-000002 6201
2026-06-18 8-K FORM 8-K 5.07 0001104659-26-075720 001-41608 261102506 34 258581 1 1
2026-05-07 10-Q 10-Q 0001104659-26-057230 001-41608 26954424 34 7194304 1 1
2026-05-07 8-K FORM 8-K 1.01,2.02,8.01,9.01 0001104659-26-057226 001-41608 26954352 34 787544 1 1
2026-05-07 424B5 424B5 0001104659-26-057160 333-289326 26953640 33 220122 1 1
2026-04-23 ARS ARS 0001104659-26-047752 001-41608 26889196 34 29385737
2026-04-23 DEF 14A DEF 14A 0001104659-26-047740 001-41608 26889106 34 3719825 1 1
2026-04-23 4 xslF345X06/form4-04232026_080401.xml 0001712069-26-000007 8143
2026-04-23 3 xslF345X06/form3-04232026_080428.xml 0001712069-26-000006 8129
2026-04-16 4 4 0001193125-26-158649 13012
2026-04-15 8-K FORM 8-K 5.02,7.01,9.01 0001104659-26-043425 001-41608 26862449 34 303321 1 1
2026-03-23 4 xslF345X06/form4-03232026_040310.xml 0001801842-26-000003 8136
2026-03-23 4 xslF345X06/form4-03232026_040308.xml 0002037144-26-000003 8231
2026-03-23 4 xslF345X06/form4-03232026_040307.xml 0001963664-26-000003 8131
2026-03-23 4 xslF345X06/form4-03232026_040305.xml 0001962926-26-000003 8133
2026-03-23 4 xslF345X06/form4-03232026_040303.xml 0001962414-26-000003 9023
2026-03-23 4 xslF345X06/form4-03232026_040301.xml 0001698149-26-000003 9080
2026-03-16 8-K FORM 8-K 7.01,8.01,9.01 0001104659-26-028023 001-41608 26754521 34 15340166 1 1
2026-03-05 4 xslF345X05/form4-03052026_060312.xml 0002037144-26-000002 5279
2026-03-05 4 xslF345X05/form4-03052026_060310.xml 0001963664-26-000002 5178
2026-03-05 4 xslF345X05/form4-03052026_060307.xml 0001962926-26-000002 5180
2026-03-05 4 xslF345X05/form4-03052026_060306.xml 0001962414-26-000002 6067
2026-03-05 4 xslF345X05/form4-03052026_060304.xml 0001801842-26-000002 10116
2026-03-05 4 xslF345X05/form4-03052026_060301.xml 0001698149-26-000002 10105
2026-02-26 S-8 FORM S-8 0001104659-26-020645 333-293821 26690621 33 263428 1 1
2026-02-26 10-K 10-K 0001104659-26-020562 001-41608 26689653 34 18277016 1 1
2026-02-26 8-K FORM 8-K 2.02,9.01 0001104659-26-020494 001-41608 26688130 34 328847 1 1
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000921895-26-000466 005-93902 26641654 34 23449
2026-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-26-000714 005-93902 26629104 34 11758
2026-02-10 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902219-26-000082 005-93902 26614320 34 17327
2026-02-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-26-000535 005-93902 26602064 34 11709
2026-01-20 4 4 0001193125-26-016062 27094
2026-01-05 8-K FORM 8-K 1.01 0001104659-26-000620 001-41608 26505998 34 249184 1 1
2025-12-10 8-K FORM 8-K 8.01,9.01 0001104659-25-120015 001-41608 251562693 34 1055641 1 1
2025-12-10 424B5 424B5 0001104659-25-120013 333-289326 251562666 33 1192734 1 1
2025-12-10 4 4 0001193125-25-313977 32028
2025-12-08 424B5 424B5 0001104659-25-119370 333-289326 251557049 33 1020407
2025-12-08 8-K FORM 8-K 7.01,8.01,9.01 0001104659-25-119095 001-41608 251554747 34 8779403 1 1
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000299 005-93902 251483253 34 9653
2025-11-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-004942 005-93902 251481642 34 15548
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-004826 005-93902 251481382 34 11743
2025-11-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902219-25-000370 005-93902 251460620 34 17311
2025-11-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902219-25-000367 005-93902 251460616 34 17320
2025-11-06 10-Q 10-Q 0001104659-25-107829 001-41608 251459361 34 8015408 1 1
2025-11-06 8-K FORM 8-K 2.02,9.01 0001104659-25-107740 001-41608 251458493 34 347241 1 1
2025-09-22 4 xslF345X05/form4-09222025_090903.xml 0001801842-25-000004 5184
2025-09-22 4 xslF345X05/form4-09222025_090901.xml 0002037144-25-000003 5280
2025-08-20 4 xslF345X05/form4-08202025_050803.xml 0001415889-25-022472 5179
2025-08-20 4 xslF345X05/form4-08202025_050801.xml 0001415889-25-022471 5181
2025-08-18 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000921895-25-002329 005-93902 251228639 34 38909
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000227 005-93902 251215835 34 9653
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-003262 005-93902 251214632 34 11775
2025-08-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902219-25-000354 005-93902 251205143 34 17307
2025-08-06 S-3ASR S-3ASR 0001104659-25-074777 333-289326 251190678 33 2391096 1 1
2025-08-06 10-Q 10-Q 0001558370-25-010541 001-41608 251190086 34 7256338 1 1
2025-08-06 8-K FORM 8-K 2.02,9.01 0001104659-25-074712 001-41608 251189515 34 338177 1 1
2025-08-06 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-002110 005-93902 251188466 34 11283
2025-08-01 4 4 0000950170-25-101141 11870
2025-07-03 4 xslF345X05/form4-07032025_050709.xml 0001415889-25-019354 13005
2025-07-03 4 xslF345X05/form4-07032025_050708.xml 0001415889-25-019353 7416
2025-07-03 4 xslF345X05/form4-07032025_050706.xml 0001415889-25-019352 7418
2025-07-03 4 xslF345X05/form4-07032025_050704.xml 0001415889-25-019351 12200
2025-07-03 4 xslF345X05/form4-07032025_050702.xml 0001415889-25-019350 13869
2025-06-25 4 xslF345X05/form4-06252025_050611.xml 0001415889-25-018218 6078
2025-06-25 4 xslF345X05/form4-06252025_050609.xml 0001415889-25-018217 6101
2025-06-25 4 xslF345X05/form4-06252025_050607.xml 0001415889-25-018216 6113
2025-06-25 4 xslF345X05/form4-06252025_050605.xml 0001415889-25-018215 6072
2025-06-25 4 xslF345X05/form4-06252025_050603.xml 0001415889-25-018214 6099
2025-06-25 4 xslF345X05/form4-06252025_050601.xml 0001415889-25-018213 6066
2025-06-25 8-K FORM 8-K 5.07 0001104659-25-062576 001-41608 251073807 34 261814 1 1
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-001964 005-93902 25948982 34 11776
2025-05-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000170 005-93902 25943992 34 9652
2025-05-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001422848-25-000060 005-93902 25938167 34 7665
2025-05-08 10-Q 10-Q 0001558370-25-006989 001-41608 25926750 34 6416486 1 1
2025-05-08 8-K FORM 8-K 2.02,9.01 0001104659-25-046149 001-41608 25926566 34 325526 1 1
2025-04-24 ARS ARS 0001104659-25-038690 001-41608 25867884 34 4584196
2025-04-24 DEF 14A DEF 14A 0001104659-25-038675 001-41608 25867799 34 3202334 1 1
2025-03-18 4 xslF345X05/form4-03182025_080313.xml 0001415889-25-008555 12035
2025-03-18 4 xslF345X05/form4-03182025_080311.xml 0001415889-25-008554 7998
2025-03-18 4 xslF345X05/form4-03182025_080308.xml 0001415889-25-008553 8003
2025-03-18 4 xslF345X05/form4-03182025_080306.xml 0001415889-25-008552 8004
2025-03-18 4 xslF345X05/form4-03182025_080303.xml 0001415889-25-008551 13825
2025-03-18 4 xslF345X05/form4-03182025_080301.xml 0001415889-25-008550 8915
2025-02-27 S-8 FORM S-8 0001104659-25-018327 333-285377 25680933 33 285976 1 1
2025-02-27 10-K 10-K 0001558370-25-001826 001-41608 25679970 34 16836254 1 1
2025-02-27 8-K FORM 8-K 2.02,9.01 0001104659-25-018275 001-41608 25679885 34 347739 1 1
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000074 005-93902 25625639 34 9666
2025-02-10 4 4 0000950170-25-016705 13320
2025-01-13 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-000177 005-93902 25526451 34 11622
2024-12-17 8-K FORM 8-K 7.01,9.01 0001104659-24-129378 001-41608 241555856 34 293860 1 1
2024-11-14 SC 13G/A SC 13G/A 0001104659-24-119301 005-93902 241464734 34 96538
2024-11-14 SC 13G JANUS NEW 0001274173-24-000095 005-93902 241458238 34 10638
2024-11-14 SC 13G/A STRUCTURE THERAPEUTICS INC. 0000902664-24-006524 005-93902 241457817 34 58581
2024-11-13 10-Q 10-Q 0001558370-24-015531 001-41608 241454509 34 9106014 1 1
2024-11-13 8-K FORM 8-K 2.02,9.01 0001104659-24-117691 001-41608 241454272 34 335802 1 1
2024-11-12 SC 13G SEC SCHEDULE 13G 0001422848-24-000335 005-93902 241446227 34 18391
2024-11-12 SC 13G/A filing.txt 0000315066-24-002903 005-93902 241444981 34 8169
2024-11-08 SC 13G/A SEC SCHEDULE 13G 0000902219-24-000453 005-93902 241438647 34 36268
2024-09-20 4 xslF345X05/form4-09202024_090932.xml 0001415889-24-023794 7741
2024-09-20 3 xslF345X02/form3-09202024_090945.xml 0001415889-24-023793 7964
2024-09-20 4 xslF345X05/form4-09202024_090935.xml 0001415889-24-023791 7846
2024-09-20 3 xslF345X02/form3-09202024_090909.xml 0001415889-24-023790 16067
2024-09-17 8-K FORM 8-K 5.02,7.01,8.01,9.01 0001104659-24-100668 001-41608 241304432 34 313505 1 1
2024-08-28 4 xslF345X05/form4-08282024_080826.xml 0001415889-24-022457 6001
2024-08-28 3 xslF345X02/form3-08282024_080851.xml 0001415889-24-022456 7944
2024-08-27 8-K FORM 8-K 5.02 0001104659-24-093434 001-41608 241249210 34 260693 1 1
2024-08-08 10-Q 10-Q 0001558370-24-011616 001-41608 241188789 34 8713768 1 1
2024-08-08 8-K FORM 8-K 2.02,9.01 0001104659-24-087275 001-41608 241188508 34 353350 1 1
2024-06-27 8-K FORM 8-K 5.07,8.01 0001104659-24-075724 001-41608 241080098 34 263845 1 1
2024-06-27 4 xslF345X05/form4-06272024_040609.xml 0001415889-24-018328 5962
2024-06-27 4 xslF345X05/form4-06272024_040607.xml 0001415889-24-018327 5973
2024-06-27 4 xslF345X05/form4-06272024_040605.xml 0001415889-24-018326 5936
2024-06-27 4 xslF345X05/form4-06272024_040603.xml 0001415889-24-018325 5959
2024-06-27 4 xslF345X05/form4-06272024_040601.xml 0001415889-24-018324 5926
2024-06-14 4 xslF345X05/form4-06152024_120647.xml 0001415889-24-017040 11477
2024-06-13 3 3 0000950170-24-072703 11779
2024-06-12 4 xslF345X05/form4-06122024_080615.xml 0001415889-24-016510 11995
2024-06-10 144 xsl144X01/primary_doc.xml 0001950047-24-004577 001-41608 241033691 33 4901
2024-06-06 424B4 424B4 0001104659-24-069103 333-279915 241025294 33 875485
2024-06-05 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-06-05 16:00:00 9999999995-24-001761 333-279915 241023759 33 1849
2024-06-05 S-1MEF S-1MEF 0001104659-24-068769 333-279983 241023536 33 146171
2024-06-05 4 xslF345X05/form4-06052024_110646.xml 0001415889-24-015683 16423
2024-06-04 UPLOAD filename1.pdf 0000000000-24-006368 001-41608 39757
2024-06-03 CORRESP filename1.htm 0001104659-24-067860 9308
2024-06-03 CORRESP filename1.htm 0001104659-24-067857 16492
2024-06-03 8-K FORM 8-K 8.01,9.01 0001104659-24-067836 001-41608 241014475 34 320082 1 1
2024-06-03 144 xsl144X01/primary_doc.xml 0001950047-24-004344 001-41608 241014383 33 5119
2024-06-03 S-1 S-1 0001104659-24-067768 333-279915 241013523 33 1697228
2024-06-03 8-K FORM 8-K 7.01,8.01,9.01 0001104659-24-067483 001-41608 241012022 34 6705217 1 1
2024-05-31 CORRESP filename1.htm 0001104659-24-067339 26947
2024-05-31 UPLOAD filename1.pdf 0000000000-24-006276 001-41608 43474
2024-05-30 SC 13G SC 13G 0001104659-24-066763 005-93902 241007117 34 80858
2024-05-24 CORRESP filename1.htm 0001104659-24-065192 26339
2024-05-22 UPLOAD filename1.pdf 0000000000-24-005955 001-41608 45231
2024-05-09 10-Q 10-Q 0001558370-24-007642 001-41608 24931641 34 8146288 1 1
2024-05-09 8-K FORM 8-K 2.02,9.01 0001104659-24-059329 001-41608 24930667 34 343904 1 1
2024-04-25 ARS ARS 0001104659-24-052077 001-41608 24877632 34 29793794
2024-04-25 DEF 14A DEF 14A 0001104659-24-051972 001-41608 24876466 34 1310892
2024-04-19 4 4 0000950170-24-045901 12517
2024-03-20 4/A xslF345X05/form4a-03202024_110328.xml 0001415889-24-008784 6314
2024-03-20 4/A xslF345X05/form4a-03202024_110306.xml 0001415889-24-008783 6318
2024-03-20 4/A xslF345X05/form4a-03202024_110344.xml 0001415889-24-008782 6310
2024-03-20 4/A xslF345X05/form4a-03202024_110339.xml 0001415889-24-008781 6291
2024-03-20 4/A xslF345X05/form4a-03202024_110300.xml 0001415889-24-008780 6293
2024-03-19 4 xslF345X05/form4-03192024_080311.xml 0001415889-24-008572 7492
2024-03-19 4 xslF345X05/form4-03192024_080346.xml 0001415889-24-008569 7488
2024-03-19 4 xslF345X05/form4-03192024_080323.xml 0001415889-24-008567 7496
2024-03-19 4 xslF345X05/form4-03192024_080315.xml 0001415889-24-008566 8346
2024-03-19 4 xslF345X05/form4-03192024_080344.xml 0001415889-24-008561 8366
2024-03-18 4 4 0000950170-24-032542 13262
2024-03-08 S-8 FORM S-8 0001104659-24-032400 333-277789 24734638 33 120816
2024-03-08 10-K 10-K 0001558370-24-002791 001-41608 24732510 34 17909745 1 1
2024-03-08 8-K FORM 8-K 2.02,9.01 0001104659-24-032121 001-41608 24732446 34 330073 1 1
2024-02-15 4 FORM 4 SUBMISSION 0001209191-24-003392 13463
2024-02-14 SC 13G STRUCTURE THERAPEUTICS INC. 0000902664-24-001595 005-93902 24632894 34 63647
2024-02-14 SC 13G/A deeptrack-gpcr123123a1.htm 0001172661-24-000922 005-93902 24632651 34 104590
2024-02-09 SC 13G/A filing.txt 0000315066-24-001513 005-93902 24612057 34 8111
2024-02-09 SC 13G/A filing.txt 0000318989-24-000063 005-93902 24611216 34 8635
2024-02-08 SC 13G SEC SCHEDULE 13G 0000902219-24-000010 005-93902 24607206 34 38049
2024-02-06 SC 13G/A SEC SCHEDULE 13G 0000902219-24-000007 005-93902 24598879 34 38044
2023-12-27 4 FORM 4 SUBMISSION 0001209191-23-059755 16793
2023-12-20 SC 13G/A AMENDMENT NO. 1 TO SCHEDULE 13G 0000921895-23-002786 005-93902 231501759 34 281080
2023-12-18 8-K FORM 8-K 7.01,8.01,9.01 0001104659-23-126639 001-41608 231492301 34 13942873 1 1
2023-12-07 4 FORM 4 SUBMISSION 0001209191-23-057698 14814
2023-11-29 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2023-11-29 16:00:00 9999999995-23-003494 333-275651 231453852 33 1800
2023-11-27 CORRESP filename1.htm 0001104659-23-121152 7947
2023-11-24 UPLOAD filename1.pdf 0000000000-23-012839 377-06964 40693
2023-11-24 UPLOAD filename1.pdf 0000000000-23-012838 40404
2023-11-20 DRS filename1.htm 0001104659-23-119958 377-06964 231423402 33 1282987
2023-11-17 S-1 S-1 0001104659-23-119620 333-275651 231420071 33 1343461
2023-11-17 10-Q 10-Q 0001558370-23-019203 001-41608 231419607 34 10400941 1 1
2023-11-17 10-Q/A 10-Q/A 0001558370-23-019202 001-41608 231419542 34 8605764 1 1
2023-11-16 10-Q/A 10-Q/A 0001558370-23-019165 001-41608 231415514 34 8714326 1 1
2023-11-14 NT 10-Q NT 10-Q 0001104659-23-118246 001-41608 231408017 34 29225
2023-11-14 8-K FORM 8-K 1.01,2.02,9.01 0001104659-23-118241 001-41608 231407974 34 560320 1 1
2023-10-23 4 FORM 4 SUBMISSION 0001209191-23-053321 15247
2023-10-13 SC 13G/A filing.txt 0000315066-23-002705 005-93902 231325069 34 8026
2023-10-12 3 FORM 3 SUBMISSION 0001209191-23-052664 9134
2023-09-29 8-K FORM 8-K 1.01,3.02,7.01,9.01 0001104659-23-105038 001-41608 231291890 34 615381 1 1
2023-09-29 8-K FORM 8-K 7.01,9.01 0001104659-23-105027 001-41608 231291848 34 5018707 1 1
2023-08-10 10-Q 10-Q 0001558370-23-014524 001-41608 231160231 34 8590075 1 1
2023-08-10 8-K FORM 8-K 2.02,9.01 0001104659-23-089815 001-41608 231159790 34 340868 1 1
2023-08-04 4 FORM 4 SUBMISSION 0001209191-23-044645 11526
2023-08-04 4 FORM 4 SUBMISSION 0001209191-23-044640 5949
2023-08-04 3 FORM 3 SUBMISSION 0001209191-23-044638 6073
2023-08-04 8-K FORM 8-K 5.02,9.01 0001104659-23-087873 001-41608 231144452 34 286727 1 1
2023-07-06 8-K FORM 8-K 1.01,9.01 0001104659-23-078719 001-41608 231073599 34 1987832 1 1
2023-06-05 8-K FORM 8-K 4.01,9.01 0001104659-23-068028 001-41608 23992471 34 275658 1 1
2023-05-12 4 xslF345X04/e618629_4-stinc.xml 0001193805-23-000724 38551
2023-05-11 10-Q 10-Q 0001558370-23-009425 001-41608 23911989 34 7683261 1 1
2023-05-11 8-K FORM 8-K 2.02,9.01 0001104659-23-059189 001-41608 23911810 34 327128 1 1
2023-03-30 10-K 10-K 0001558370-23-005141 001-41608 23781756 34 7694694
2023-03-30 8-K FORM 8-K 2.02,9.01 0001104659-23-039267 001-41608 23781748 34 345072 1 1
2023-02-13 3 OWNERSHIP DOCUMENT 0000921895-23-000482 26025
2023-02-13 SC 13G THE SCHEDULE 13G 0000921895-23-000463 005-93902 23620173 34 288161
2023-02-10 SC 13G filing.txt 0000318989-23-000055 005-93902 23608821 34 8489
2023-02-10 SC 13G filing.txt 0000315066-23-002177 005-93902 23608798 34 8043
2023-02-09 4 FORM 4 SUBMISSION 0001209191-23-008168 7413
2023-02-09 4 FORM 4 SUBMISSION 0001209191-23-008166 10620
2023-02-09 4 FORM 4 SUBMISSION 0001209191-23-008164 5659
2023-02-09 4 FORM 4 SUBMISSION 0001209191-23-008163 5699
2023-02-09 4 FORM 4 SUBMISSION 0001209191-23-008160 5667
2023-02-09 4 FORM 4 SUBMISSION 0001209191-23-008159 5992
2023-02-09 4 PRIMARY DOCUMENT 0000315066-23-002162 40983
2023-02-09 4 PRIMARY DOCUMENT 0000318989-23-000054 40740
2023-02-07 8-K FORM 8-K 5.03,9.01 0001104659-23-011717 001-41608 23595011 34 269206
2023-02-06 S-8 FORM S-8 0001104659-23-011247 333-269601 23591356 33 169706
2023-02-06 4 FORM 4 SUBMISSION 0001209191-23-007317 5512
2023-02-06 4 FORM 4 SUBMISSION 0001209191-23-007314 5518
2023-02-06 424B4 424B4 0001104659-23-010729 333-269200 23587645 33 19202546
2023-02-03 SEC STAFF LETTER filename1.pdf 9999999997-23-000500 273872
2023-02-03 SC 13G deeptrack-gpcr020323.htm 0001172661-23-000436 005-93902 23586494 34 104433
2023-02-02 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2023-02-02 16:45:00 9999999995-23-000260 333-269200 23583596 33 1799
2023-02-02 EFFECT xslEFFECTX01/primary_doc.xml F-6,,2023-02-02 16:45:00 9999999995-23-000262 333-269454 23583594 33 1799
2023-02-02 3 FORM 3 SUBMISSION 0001209191-23-006399 7410
2023-02-02 3 PRIMARY DOCUMENT 0000318989-23-000007 20542
2023-02-02 3 FORM 3 SUBMISSION 0001209191-23-006395 7362
2023-02-02 3 FORM 3 SUBMISSION 0001209191-23-006393 7384
2023-02-02 3 FORM 3 SUBMISSION 0001209191-23-006392 8758
2023-02-02 3 FORM 3 SUBMISSION 0001209191-23-006390 8842
2023-02-02 3 FORM 3 SUBMISSION 0001209191-23-006389 7434
2023-02-02 3 FORM 3 SUBMISSION 0001209191-23-006382 7407
2023-02-02 3 FORM 3 SUBMISSION 0001209191-23-006372 7446
2023-02-02 3 FORM 3 SUBMISSION 0001209191-23-006365 9760
2023-02-02 3 PRIMARY DOCUMENT 0000315066-23-000041 16083
2023-02-02 3 FORM 3 SUBMISSION 0001209191-23-006356 10013
2023-02-02 3 FORM 3 SUBMISSION 0001209191-23-006349 10036
2023-02-02 S-1MEF FORM S-1MEF 0001104659-23-010008 333-269542 23582439 33 176503
2023-02-02 CERT 8A_Cert_GPCR.pdf 0001354457-23-000065 001-41608 23579966 34 218035
2023-01-31 CORRESP filename1.htm 0001104659-23-008579 21497
2023-01-31 CORRESP filename1.htm 0001104659-23-008578 10063
2023-01-30 8-A12B FORM 8-A12B 0001104659-23-007953 001-41608 23567645 34 20214
2023-01-30 S-1/A S-1/A 0001104659-23-007657 333-269200 23565099 33 20503239
2023-01-30 F-6 e618218_f6-sti.htm 0001193805-23-000081 333-269454 23565091 33 478510
2023-01-23 CORRESP filename1.htm 0001104659-23-005794 119612
2023-01-12 CORRESP filename1.htm 0001104659-23-003421 24463
2023-01-12 S-1 S-1 0001104659-23-003415 333-269200 23526173 33 26170045
2023-01-04 UPLOAD filename1.pdf 0000000000-23-000116 46353
2022-12-06 DRS/A filename1.htm 0001104659-22-124662 377-06019 221446438 33 15703591
2022-12-05 DRSLTR filename1.htm 0001104659-22-124664 22616
2022-05-27 UPLOAD filename1.pdf 0000000000-22-005860 46199
2022-05-13 DRS/A filename1.htm 0001104659-22-059724 377-06019 22920010 33 12457854
2022-05-12 DRSLTR filename1.htm 0001104659-22-059729 68607
2022-03-16 SEC STAFF LETTER filename1.pdf 9999999997-22-000898 275853
2022-03-14 UPLOAD filename1.pdf 0000000000-22-002782 70250
2022-02-14 DRS filename1.htm 0001104659-22-021024 377-06019 22624480 33 14299900
2022-01-10 D xslFormDX01/primary_doc.xml 06b 0001888886-22-000001 021-428629 22521113 33 12601
2021-10-21 D xslFormDX01/primary_doc.xml 06b 0001888886-21-000003 021-417860 211335156 33 13924
2021-10-21 D xslFormDX01/primary_doc.xml 06b 0001888886-21-000002 021-417848 211335104 33 12512
2021-10-21 D xslFormDX01/primary_doc.xml 06b 0001888886-21-000001 021-417842 211335066 33 12512

Latest XBRL company facts

One latest value per concept from companyfacts (230 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 214.77M 2026-10-31 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
dei EntityPublicFloat Entity Public Float USD 834.90M 2025-06-30 2025 FY 10-K 2026-02-26 0001104659-26-020562
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 11.42M 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001104659-26-047740
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 3.05M 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001104659-26-047740
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 134.82 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001104659-26-047740
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 36.23M 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001104659-26-047740
ecd PeoTotalCompAmt PeoTotalCompAmt USD 8.43M 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001104659-26-047740
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 267.5 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001104659-26-047740
ffd NetFeeAmt NetFeeAmt USD 20,715 2026-05-06 424B5 2026-05-07 0001104659-26-057160
ffd NrrtvMaxAggtOfferingPric NrrtvMaxAggtOfferingPric USD 400.00M 2026-05-06 424B5 2026-05-07 0001104659-26-057160
ffd TtlFeeAmt TtlFeeAmt USD 58,990 2026-05-06 424B5 2026-05-07 0001104659-26-057160
ffd TtlOfferingAmt TtlOfferingAmt USD 400.00M 2026-05-06 424B5 2026-05-07 0001104659-26-057160
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-05-06 424B5 2026-05-07 0001104659-26-057160
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 38,275 2026-05-06 424B5 2026-05-07 0001104659-26-057160
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 33.88M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 3.57M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 2.97M 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -4.69M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 2.02B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Decrease for Tax Withholding Obligation USD 500,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock Adjustments to Additional Paid in Capital, Increase in Carrying Amount of Redeemable Preferred Stock USD 1.51M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-08 0001558370-24-002791
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 12.73M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 37.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 24.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap AssetRetirementObligationAccretionExpense Asset Retirement Obligation, Accretion Expense USD 29,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-06 0001104659-26-092057
us-gaap AssetRetirementObligationLiabilitiesIncurred Asset Retirement Obligation, Liabilities Incurred USD 239,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap AssetRetirementObligationPeriodIncreaseDecrease Asset Retirement Obligation, Period Increase (Decrease) USD 239,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-06 0001104659-26-092057
us-gaap Assets Assets USD 1.33B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap AssetsCurrent Assets, Current USD 1.28B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 1.24B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 1.07M 2025-12-31 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 4.69M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 219.95M 2023-06-30 2023 Q2 10-Q/A 2023-11-17 0001558370-23-019202
us-gaap AvailableForSaleDebtSecuritiesGrossUnrealizedGain Debt Securities, Available-for-sale, Unrealized Gain USD 4,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-17 0001558370-23-019203
us-gaap AvailableForSaleDebtSecuritiesGrossUnrealizedLoss Debt Securities, Available-for-sale, Unrealized Loss USD 314,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-17 0001558370-23-019203
us-gaap AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value USD 879.60M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 667,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 222.03M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 1.24B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 222.03M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -577.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight Class of Warrant or Right, Number of Securities Called by Each Warrant or Right shares 1 2024-12-31 2024 FY 10-K 2025-02-27 0001558370-25-001826
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 38.25M 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 500.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 214.09M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 214.09M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap CommonStockValue Common Stock, Value, Issued USD 21,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -332.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 67.02M 2023-02-07 2024 FY 10-K 2025-02-27 0001558370-25-001826
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 427,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 436,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 9,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap DebtSecuritiesAvailableForSaleAllowanceForCreditLoss Debt Securities, Available-for-sale, Allowance for Credit Loss USD 0 2023-06-30 2023 Q2 10-Q/A 2023-11-17 0001558370-23-019202
us-gaap DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss USD 1.24B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap DebtSecuritiesAvailableForSaleExcludingAccruedInterest DebtSecuritiesAvailableForSaleExcludingAccruedInterest USD 1.24B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 79,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 1.33M 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 108.34M 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 36.46M 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 57,000 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 913,000 2024-12-31 2024 FY 10-K 2025-02-27 0001558370-25-001826
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 55.31M 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 250,000 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 18,000 2022-12-31 2023 FY 10-K 2024-03-08 0001558370-24-002791
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 9.58M 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 5.05M 2024-12-31 2024 FY 10-K 2025-02-27 0001558370-25-001826
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits USD 3.39M 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 1.74M 2023-12-31 2023 FY 10-K 2024-03-08 0001558370-24-002791
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 2.11M 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 106.95M 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 111,000 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 78,000 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap DeferredTaxLiabilitiesTaxDeferredIncome Deferred Tax Liabilities, Tax Deferred Income USD 77,000 2023-12-31 2023 FY 10-K 2024-03-08 0001558370-24-002791
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 1.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap DefinedContributionPlanEmployerMatchingContributionPercent Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay pure 0.04 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match pure 1 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap Depreciation Depreciation USD 1.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap DividendsCommonStock Dividends, Common Stock USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -1.5 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -1.5 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -0.004 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.205 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure -0.04 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0001558370-25-001826
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure -0.002 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0001558370-25-001826
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure 0.001 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-08 0001558370-24-002791
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.003 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.037 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.015 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0001558370-25-001826
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure -0.017 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0001558370-25-001826
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure -0.01 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.036 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 12.13M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 75.50M 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 63.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -144.08M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -326.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 3.39M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 634,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 595,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap IncomeTaxPaidForeignAfterRefundReceived IncomeTaxPaidForeignAfterRefundReceived USD 619,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 28.79M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -29.54M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 67,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount USD 80.50M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-08 0001558370-24-002791
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 5.22M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -187,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 1.45M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 5.12M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 21.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap IncreaseDecreaseInAssetRetirementObligations Increase (Decrease) in Asset Retirement Obligations USD -13,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap IncreaseDecreaseInDeferredIncomeTaxes Increase (Decrease) in Deferred Income Taxes USD -121,000 2022-01-01 2022-06-30 2023 Q2 10-Q/A 2023-11-17 0001558370-23-019202
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -2.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 41.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD 507,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap IncreaseDecreaseInOtherReceivables Increase (Decrease) in Other Receivables USD -100.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 11.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap InvestmentIncomeNetAmortizationOfDiscountAndPremium Investment Income, Net, Amortization of Discount and Premium USD 9.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 7.48M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 2.90M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 938,000 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 947,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 2.68M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 959,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 656,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap Liabilities Liabilities USD 112.55M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 1.33B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap LiabilitiesCurrent Liabilities, Current USD 107.10M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 1.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -372.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -206.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -326.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -86.05M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-13 0001558370-24-015531
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap OperatingExpenses Operating Expenses USD 364.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -364.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap OperatingLeaseCost Operating Lease, Cost USD 3.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 6.83M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 2.76M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 4.07M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap OperatingLeasePayments Operating Lease, Payments USD 2.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 6.58M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.077 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 2.27M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 42.45M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD -5.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -5.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap OtherLiabilities Other Liabilities USD 300,000 2024-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 1.38M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 100.00M 2025-12-31 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 37,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 21.57M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-08 0001558370-24-002791
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 3.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 4.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 775.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 100.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2023-03-31 2023 Q1 10-Q 2023-05-11 0001558370-23-009425
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2023-03-31 2023 Q1 10-Q 2023-05-11 0001558370-23-009425
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 35.15M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 166.70M 2023-02-01 2023-02-28 2026 Q1 10-Q 2026-05-07 0001104659-26-057230
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 57.06M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 300.00M 2023-01-01 2023-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock Proceeds from Issuance of Redeemable Convertible Preferred Stock USD 31.50M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-08 0001558370-24-002791
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised USD 872,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 94.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments Proceeds from Maturities, Prepayments and Calls of Short-term Investments USD 408.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 3.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -326.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 9.62M 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 10.26M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 301.12M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -797.18M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 2.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 37.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 1.013 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-08 0001558370-24-002791
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.037 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-08 0001558370-24-002791
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized shares 5.57M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-13 0001558370-24-015531
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 10.97M 2024-09-30 2024 Q3 10-Q 2024-11-13 0001558370-24-015531
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 147.46M 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 8.10M 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 4.98 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 11.90M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 671,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 4.72M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 253.90M 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 15.36M 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 6.65 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 253.90M 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 15.36M 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 6.65 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 24.90M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value USD/shares 5.95 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 3.5 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 11.48 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 7.22 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap ShortTermInvestments Short-term Investments USD 1.02B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 1.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 1.22B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 1 2023-02-07 2024 FY 10-K 2025-02-27 0001558370-25-001826
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 90.19M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-13 0001558370-24-015531
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 1.29M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 199.97M 2023-01-01 2023-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 872,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 281.46M 2023-01-01 2023-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 1.23M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 6,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-08 0001558370-24-002791
us-gaap TemporaryEquityAccretionToRedemptionValueAdjustment Temporary Equity, Accretion to Redemption Value, Adjustment USD 1.51M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-08 0001558370-24-002791
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 0 2024-06-30 2024 Q2 10-Q 2024-08-08 0001558370-24-011616
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 198.02M 2022-12-31 2023 FY 10-K 2024-03-08 0001558370-24-002791
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 67.02M 2022-12-31 2023 FY 10-K 2024-03-08 0001558370-24-002791
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 0 2024-12-31 2024 FY 10-K 2025-02-27 0001558370-25-001826
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2024-12-31 2024 FY 10-K 2025-02-27 0001558370-25-001826
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 9.50M 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 17,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2023-12-31 2023 FY 10-K 2024-03-08 0001558370-24-002791
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 1.55M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 6.25M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 38.80M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001104659-26-020562
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 217.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap WeightedAverageNumberOfSharesContingentlyIssuable Weighted Average Number of Shares, Contingently Issuable shares 4.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap WeightedAverageNumberOfSharesIssuedBasic Weighted Average Number of Shares Issued, Basic shares 213.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 217.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124503

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →